nonprofit generic medicine company

Civica Rx

Industry Health

A nonprofit generic-drug organization created by health systems and philanthropies to reduce drug shortages and make essential medicines more affordable. Civica Rx scores well because the model leaves more value with stakeholders and the institution is less hostile to people with weak bargaining power, and no current penalty outweighs that structure.

Why this matters: Civica is a strong medicine infrastructure entry because its nonprofit design directly targets shortage, price, and access failures in pharmaceutical markets.

Letter grade B Qualified Medium confidence (AI) Rubric gcd-rubric-v1 Last reviewed May 11, 2026

Final Score 49* B - Qualified

BQUALIFIED49 pts

* Tentative scaffolding score. Not human-checked or final.

Base Material55

Bonus+0

Cap66No structure cap

After Cap55

Penalties-6

!Not Verified

Represent this organization?

Request verification to have the evidence record checked against primary materials and organization-supplied documents. Verification does not buy a higher score; scores change only when review finds factual errors, omissions, or miscalibration.

Request verification

Evaluation Overview

B - Qualified

The score turns mainly on Extraction, with the largest penalty coming from Animal Testing.

Strengths

Extraction8/10
Ownership7/10
Solidarity with the Unemployed7/7

Penalties

Animal Testing-6

Evidence state

ConfidenceMedium confidence (AI)
ThoroughnessDeveloped (AI)
Linked claims4
Direct axis claims4
Coverage4/10

Scoring Axes

Axis	Score	Why this score
Ownership ? Control rights: shareholder-dominated at 0, worker cooperative control at 10.	7 / 10	The linked record identifies Civica Rx as a nonprofit generic-drug company founded by health systems and philanthropies, describes conduct considered under Ownership relative to investor-owned pharma. The linked record identifies Civica Rx as a nonprofit generic-drug company founded by health systems and philanthropies, describes conduct considered under Ownership relative to investor-owned pharma. That places Civica Rx in the middle of Ownership: there is some mission, member, producer, or public-interest constraint, but decisive control is not fully democratic. The value stays below the top tier because the linked record does not show full democratic control, non-extractive lock-in, or complete stakeholder protection on this axis. Linked evidence Civica Rx describes itself as a nonprofit generic-drug company founded by health systems and philanthropies, describes conduct considered under Ownership relative to investor-owned pharma. [1]
Governance ? Binding decision authority: centralized control at 0, democratic stakeholder control at 10.	6 / 10	The linked record identifies Civica Rx as a nonprofit generic-drug company founded by health systems and philanthropies, describes conduct considered under Ownership relative to investor-owned pharma. The linked record identifies Civica Rx as a nonprofit generic-drug company founded by health systems and philanthropies, describes conduct considered under Ownership relative to investor-owned pharma. That places Civica Rx in the middle of Governance: there are accountability mechanisms, but they stop short of broad democratic control. The value stays below the top tier because the linked record does not show full democratic control, non-extractive lock-in, or complete stakeholder protection on this axis. Linked evidence context Civica Rx describes itself as a nonprofit generic-drug company founded by health systems and philanthropies, describes conduct considered under Ownership relative to investor-owned pharma. [1] context Civica focuses on essential generic medicines and drug-shortage mitigation, supporting high Product Integrity for ordinary health needs. [2] context Civica’s stated purpose is to reduce shortages and lower costs for essential medicines, provides evidence for the relevant scoring judgment. [3]
Extraction ? Surplus allocation, wage share, CEO pay ratio, margins, and structured extraction judgment.	8 / 10	The linked record identifies Civica Rx as a nonprofit generic-drug company founded by health systems and philanthropies, describes conduct considered under Ownership relative to investor-owned pharma. The linked record identifies Civica Rx as a nonprofit generic-drug company founded by health systems and philanthropies, describes conduct considered under Ownership relative to investor-owned pharma. That places Civica Rx high on Extraction: surplus is structurally routed toward workers, producers, users, or public benefit instead of being primarily captured upward. A still-higher or maximum value requires stronger proof that this structure is durable, broad, and not merely discretionary. Linked evidence context Civica Rx describes itself as a nonprofit generic-drug company founded by health systems and philanthropies, describes conduct considered under Ownership relative to investor-owned pharma. [1] context Civica focuses on essential generic medicines and drug-shortage mitigation, supporting high Product Integrity for ordinary health needs. [2] context Civica’s stated purpose is to reduce shortages and lower costs for essential medicines, provides evidence for the relevant scoring judgment. [3]
Labor Sovereignty ? Worker power: coercive conditions at 0, co-determination or ownership at 7. Employee dissatisfaction matters only when source-backed evidence shows concrete limits on worker agency, such as coercive scheduling, retaliation, wage theft, harassment, unsafe conditions, suppression of worker voice, or extreme turnover.	5 / 7	The linked record identifies Civica Rx as a nonprofit generic-drug company founded by health systems and philanthropies, describes conduct considered under Ownership relative to investor-owned pharma. The linked record identifies Civica Rx as a nonprofit generic-drug company founded by health systems and philanthropies, describes conduct considered under Ownership relative to investor-owned pharma. That places Civica Rx in the middle of Labor Sovereignty: workers or participants have some protection or agency, but not enough binding power to control the relationship. The value stays below the top tier because the linked record does not show full democratic control, non-extractive lock-in, or complete stakeholder protection on this axis. Linked evidence context Civica Rx describes itself as a nonprofit generic-drug company founded by health systems and philanthropies, describes conduct considered under Ownership relative to investor-owned pharma. [1] context Civica focuses on essential generic medicines and drug-shortage mitigation, supporting high Product Integrity for ordinary health needs. [2] context Civica’s stated purpose is to reduce shortages and lower costs for essential medicines, provides evidence for the relevant scoring judgment. [3]
Solidarity with the Unemployed ? Treatment of exits and nonworkers, including severance, redeployment, and non-competes.	7 / 7	The linked record identifies Civica Rx as a nonprofit generic-drug company founded by health systems and philanthropies, describes conduct considered under Ownership relative to investor-owned pharma. The linked record identifies Civica Rx as a nonprofit generic-drug company founded by health systems and philanthropies, describes conduct considered under Ownership relative to investor-owned pharma. That places Civica Rx high on Solidarity with the Unemployed: the institution materially supports people outside ordinary employment rather than treating exit as abandonment. A still-higher or maximum value requires stronger proof that this structure is durable, broad, and not merely discretionary. Linked evidence context Civica Rx describes itself as a nonprofit generic-drug company founded by health systems and philanthropies, describes conduct considered under Ownership relative to investor-owned pharma. [1] context Civica focuses on essential generic medicines and drug-shortage mitigation, supporting high Product Integrity for ordinary health needs. [2] context Civica’s stated purpose is to reduce shortages and lower costs for essential medicines, provides evidence for the relevant scoring judgment. [3]
Loss-Bearing Fidelity ? Willingness to absorb costs to preserve values, workers, users, and public obligations.	7 / 7	The linked record identifies Civica Rx as a nonprofit generic-drug company founded by health systems and philanthropies, describes conduct considered under Ownership relative to investor-owned pharma. The linked record identifies Civica Rx as a nonprofit generic-drug company founded by health systems and philanthropies, describes conduct considered under Ownership relative to investor-owned pharma. That places Civica Rx high on Loss-Bearing Fidelity: the institution is structured to absorb real costs rather than shifting losses onto weaker parties. A still-higher or maximum value requires stronger proof that this structure is durable, broad, and not merely discretionary. Linked evidence context Civica Rx describes itself as a nonprofit generic-drug company founded by health systems and philanthropies, describes conduct considered under Ownership relative to investor-owned pharma. [1] context Civica focuses on essential generic medicines and drug-shortage mitigation, supporting high Product Integrity for ordinary health needs. [2] context Civica’s stated purpose is to reduce shortages and lower costs for essential medicines, provides evidence for the relevant scoring judgment. [3]
Market Conduct ? Pricing fairness, switching costs, lock-in, and rent extraction.	5 / 5	Civica’s stated purpose is to reduce shortages and lower costs for essential medicines, provides evidence for the relevant scoring judgment. Civica’s stated purpose is to reduce shortages and lower costs for essential medicines, provides evidence for the relevant scoring judgment. That places Civica Rx high on Market Conduct: pricing, access, switching, and bargaining practices show restraint compared with ordinary rent-seeking competitors. A still-higher or maximum value requires stronger proof that this structure is durable, broad, and not merely discretionary. Linked evidence Civica’s stated purpose is to reduce shortages and lower costs for essential medicines, provides evidence for the relevant scoring judgment. [3]
Product Integrity ? Preservation of quality rather than degradation for monetization.	5 / 5	Civica focuses on essential generic medicines and drug-shortage mitigation, supporting high Product Integrity for ordinary health needs. Civica focuses on essential generic medicines and drug-shortage mitigation, supporting high Product Integrity for ordinary health needs. That places Civica Rx high on Product Integrity: the core offering is genuinely useful and comparatively less dependent on traps, degradation, or harmful dependencies. A still-higher or maximum value requires stronger proof that this structure is durable, broad, and not merely discretionary. Linked evidence Civica focuses on essential generic medicines and drug-shortage mitigation, supporting high Product Integrity for ordinary health needs. [2]
Scale Integrity ? Whether growth improves or degrades fairness and accountability.	5 / 5	The linked record identifies Civica Rx as a nonprofit generic-drug company founded by health systems and philanthropies, describes conduct considered under Ownership relative to investor-owned pharma. The linked record identifies Civica Rx as a nonprofit generic-drug company founded by health systems and philanthropies, describes conduct considered under Ownership relative to investor-owned pharma. That places Civica Rx high on Scale Integrity: growth appears compatible with accountability, quality, and stakeholder benefit. A still-higher or maximum value requires stronger proof that this structure is durable, broad, and not merely discretionary. Linked evidence context Civica Rx describes itself as a nonprofit generic-drug company founded by health systems and philanthropies, describes conduct considered under Ownership relative to investor-owned pharma. [1] context Civica focuses on essential generic medicines and drug-shortage mitigation, supporting high Product Integrity for ordinary health needs. [2] context Civica’s stated purpose is to reduce shortages and lower costs for essential medicines, provides evidence for the relevant scoring judgment. [3]

Penalties

Penalty	Applied	Why this penalty
Animal Testing ? Direct animal testing, contract animal testing, animal-testing-dependent product development, or business lines where current safety/regulatory approval normally relies on animal experiments. Stronger penalties apply where animal testing is core, repeated, non-optional, or avoidable; documented cruelty-free or non-animal methods reduce or eliminate the penalty. Range: -8 to 0.	-6	Pharmaceutical, medical-product, or drug-development business models remain structurally tied to animal-testing systems in current regulated product development. Linked evidence Civica Rx has drug/medical product development animal-testing exposure based on its listed business model and current profile description: A nonprofit generic-drug organization created by health systems and philanthropies to reduce drug shortages and make essential medicines more affordable. Civica Rx scores well because the model leaves more value with st… [4]

Bonus Credits

No bonus credits applied in this version.

Confidence Basis

Confidence is computed from the evidence trail and review state, not typed into the profile by hand.

Medium 72/100

4 verified linked claims 4 direct axis claims 0 disputed claims 4/10 components covered

This confidence label measures the source-backed evidence trail. AI-scaffolded scores remain tentative until human review.

Claim confidence 20/20

4 verified linked claims

Source quality 13/18

Best source per verified claim, weighted by institutional reliability

Direct axis-specific claims 6/18

4 direct claims across 10 active components

Dispute load 12/12

0 disputed claims on this entity

Recency 10/10

Newest accepted timestamp: May 13, 2026

Reviewer status 7/12

Human-reviewed components score higher than AI scaffolding

Component coverage 4/10

4/10 evidence-bearing components have direct support

Evidence State

Profile stateAI draft / human-pending

VerificationUnverified

ConfidenceMedium confidence (AI)

ThoroughnessDeveloped (AI)

Correction routeUse “Challenge this rating” for factual errors, missing counterevidence, source problems, or calculation mistakes.

Company responseCompany representatives can submit source-backed corrections; payment never changes scores or reviewer authority.

Claims and Sources

Claims are the evidence record. Each claim needs a source link, axis category, status, confidence level, and timestamp before it can support a score.

* Tentative scaffolding score. Not human-checked or final.

1Civica Rx describes itself as a nonprofit generic-drug company founded by health systems and philanthropies, describes conduct considered under Ownership relative to investor-owned pharma.

Ownership Verified High confidence AI-generated / human-pending May 11, 2026

AI scaffold

Civica Rx AboutOfficial self-description · 68%

2Civica focuses on essential generic medicines and drug-shortage mitigation, supporting high Product Integrity for ordinary health needs.

Product Integrity Verified High confidence AI-generated / human-pending May 11, 2026

AI scaffold

Civica Rx MedicinesGeneral web source · 58%

3Civica’s stated purpose is to reduce shortages and lower costs for essential medicines, provides evidence for the relevant scoring judgment.

Market Conduct Verified High confidence AI-generated / human-pending May 11, 2026

AI scaffold

Civica Rx AboutOfficial self-description · 68%

4Civica Rx has drug/medical product development animal-testing exposure based on its listed business model and current profile description: A nonprofit generic-drug organization created by health systems and philanthropies to reduce drug shortages and make essential medicines more affordable. Civica Rx scores well because the model leaves more value with st…

Animal Testing Verified High confidence Human-reviewed May 11, 2026

Civica Rx public siteGeneral web source · 58%
FDA: Animal Welfare, Testing and Research of FDA-Regulated ProductsPrimary public record · 100%

Alternatives

Competitors

AGOOD66 Patient Advocate Foundation nonprofit patient case-management and financial-aid resource · same market AGOOD54 Federally Qualified Health Centers publicly supported community health-center system · same market AGOOD53 OpenNotes academic healthcare-transparency initiative · same market AGOOD50 CPESN USA network of independent community pharmacies · same market BQUALIFIED43 Planned Parenthood nonprofit reproductive and sexual healthcare federation · same market CPERFORMATIVE41 En-Vision America / ScriptAbility accessible prescription-labeling company · same market CPERFORMATIVE41 Mark Cuban Cost Plus Drug Company public-benefit online pharmacy · same market CPERFORMATIVE40 Cleveland Clinic nonprofit academic medical center and health system · same market

Help Improve This Profile

Submit source-backed evidence or challenge a specific claim, source, axis value, or calculation below.

How This Page Is Maintained

Evidence comes in through contributors, is checked by verifiers, and is synthesized by reviewers. Founder authority remains narrow and visible; scores recalculate when verified claims or the rubric change.

Civic Note

Incorporation, limited liability, market access, and other institutional privileges are public grants. Good Companies Directory treats those privileges as conditional on accountability to workers, users, communities, and the public.

Submit evidence for Civica Rx Add one source-backed fact for review.

Challenge this rating Point to a specific score, claim, source, or calculation problem.

Audit Log

Recent public changes for this company or group. The full audit log is part of the Transparency record.

No company-specific audit entries have been published yet.

View Full Audit Log